Targeting the glia-induced CDK5 expression that enforces antigenic escape of brain metastasis

Ended Project Grant Awarded Last action

Award ID
W81XWH2210064
Recipient
Awarding agency
Obligated
$729,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The University of Texas MD Anderson Cancer Center will target glia-induced CDK5 expression that enforces antigenic escape of brain metastasis under a $729,000 project grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the Department of Defense to support innovative biomedical research that transforms military and public health care. Through basic, applied, and advanced research over three years from September 2022 to August 2025, MD Anderson aims to investigate medical solutions for the battlefield by exploring how glial cells in the brain microenvironment alter CDK5 expression to allow cancerous tumors to evade the immune system during metastasis. Insights from this research could help develop new treatment strategies for brain metastases.

Quick answers

Who received award W81XWH2210064?

W81XWH2210064 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on September 1, 2022.

How much is award W81XWH2210064 worth?

$729,000 has been obligated on W81XWH2210064.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login